CRH Medical Corp (TSE:CRH) had its price objective hoisted by investment analysts at Royal Bank Of Canada from C$7.00 to C$8.50 in a research note issued on Monday, StockTargetPrices.com reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 1.67% from the company’s current price.
A number of other brokerages also recently weighed in on CRH. RBC Capital Markets set a C$6.50 price target on shares of CRH Medical Corp and gave the stock an “outperform” rating in a report on Thursday, October 6th. CIBC reissued an “outperform” rating on shares of CRH Medical Corp in a report on Tuesday, September 13th. Finally, Bloom Burton reissued a “buy” rating on shares of CRH Medical Corp in a report on Friday, October 28th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. CRH Medical Corp currently has an average rating of “Buy” and a consensus target price of C$6.90.
Shares of CRH Medical Corp (TSE:CRH) traded down 9.09% during midday trading on Monday, reaching $7.60. 794,781 shares of the company’s stock were exchanged. The company has a market cap of $549.68 million and a P/E ratio of 77.55. CRH Medical Corp has a 12 month low of $2.98 and a 12 month high of $8.48. The firm has a 50 day moving average price of $6.74 and a 200 day moving average price of $5.26.